Johns Hopkins University , An Evidence-based Approach to the Diagnosis and Treatment of Neurotrophic Keratitis_Monograph, 3/1/2020 12:00:00 AM - 3/1/2023 12:00:00 AM, Neurotrophic keratopathy (NK) is a serious and rare degenerative corneal disease caused by impairment in the trigeminal innervation of the cornea. Epithelial breakdown can lead to ulceration, melting of the stroma, and ultimately to corneal perforation. Significant damage may be avoided with appropriate therapeutic options when given in a timely manner.
The goal of this CME monograph is to educate eye care providers on the latest scientific understanding of NK, including:
TARGET AUDIENCE
Cornea specialists, comprehensive ophthalmologists, and optometrists.
HOW TO OBTAIN CME CREDIT
You must participate in the entire activity to receive credit, read the objectives, view the content, and complete the posttest and evaluation. A passing score is defined as answering 70% posttest questions correctly. Upon submission of the completed materials, and if a satisfactory score on the posttest has been achieved, The Johns Hopkins University School of Medicine will issue your AMA PRA Category 1 Credit(s)™ Certificate.
EVALUATION AND OUTCOMES SURVEY
Post activity, an online evaluation form will be available to attendees to evaluate the activity and identify future educational needs. Upon completion of the evaluation, the learner must attest to the number of hours in attendance. A certificate of attendance will be available immediately for download or print. The last day to evaluate the material and attest to your credits is March 1, 2023.
RELEASE DATE: March 1, 2020
EXPIRATION DATE: March 1, 2023
FOR FURTHER INFORMATION
General Information: (410) 955-2959
E-mail the Office of CME: [email protected]
The goal of this CME monograph is to educate eye care providers on the latest scientific understanding of NK, including:
- clinical manifestations and complications;
- conditions associated with the development of NK and populations at risk;
- the importance of early detection and early management;
- screening and diagnostic strategies; and
- optimal management strategies including emerging treatments and the latest clinical data (safety, efficacy, and mechanism of action [MOA]).
TARGET AUDIENCE
Cornea specialists, comprehensive ophthalmologists, and optometrists.
HOW TO OBTAIN CME CREDIT
You must participate in the entire activity to receive credit, read the objectives, view the content, and complete the posttest and evaluation. A passing score is defined as answering 70% posttest questions correctly. Upon submission of the completed materials, and if a satisfactory score on the posttest has been achieved, The Johns Hopkins University School of Medicine will issue your AMA PRA Category 1 Credit(s)™ Certificate.
EVALUATION AND OUTCOMES SURVEY
Post activity, an online evaluation form will be available to attendees to evaluate the activity and identify future educational needs. Upon completion of the evaluation, the learner must attest to the number of hours in attendance. A certificate of attendance will be available immediately for download or print. The last day to evaluate the material and attest to your credits is March 1, 2023.
RELEASE DATE: March 1, 2020
EXPIRATION DATE: March 1, 2023
FOR FURTHER INFORMATION
General Information: (410) 955-2959
E-mail the Office of CME: [email protected]
